NANarges Arbabi

Narges Arbabi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Narges Arbabi has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Mohammad Ali Mashhadi

    Department of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

    3 shared publications
  • Mahdi Atabaki

    Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

    2 shared publications
  • Saman Sargazi

    Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan 9816743463, Iran

    2 shared publications
  • Abolghasem Allahyari

    Department of Hematology and Medical Oncology Mashhad University of Medical Sciences Mashhad Iran

    1 shared publication
  • Ahmad Mehravaran

    Infectious Diseases and Tropical Medicine Research Center, Research Institute of Cellular and Molecular Science in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran

    1 shared publication
  • Danial Jahantigh

    1 shared publication

Latest Publications

  • Open Access

    The Role of lncRNAs in the TNF Pathway in Patients with COVID-19: A Narrative Review

    by Mahdi Atabaki, Narges Arbabi, Hossein Shahriari

    Context: SARS-CoV-2 infection can trigger a severe inflammatory response and, in critical cases, cytokine storm syndrome. Tumor necrosis factor-alpha (TNF-α) is a key cytokine involved in this process. Long non-coding RNAs (lncRNAs), which regulate gene expression and immune responses, may modulate TNF-α-related inflammatory pathways in COVID-19. Evidence Acquisition: This review examined the role of lncRNAs involved in the TNF pathway in patients with COVID-19, focusing on their regulatory mechanisms, associations with disease severity, and potential clinical applications. Results: Several lncRNAs, including NEAT1 (Nuclear Enriched Abundant Transcript 1), MALAT1 (Metastasis-Associated Lung Adenocarcinoma Transcript 1), THRIL (TNF-alpha and hnRNPL Related Immunoregulatory LncRNA), GAS5 (Growth Arrest-Specific 5), TUG1 (Taurine Up-Regulated 1), and HULC (Highly Upregulated in Liver Cancer), were found to modulate TNF-α and other inflammatory cytokines via mechanisms such as microRNA sponging, epigenetic regulation, and transcriptional control. Evidence from immune interventions, including BCG vaccination and immunonutrition, as well as bioinformatics-based network analyses, further supports the involvement of lncRNAs in the regulation of the TNF pathway. Altered expression of these lncRNAs was associated with COVID-19 severity, prognosis, and treatment response. Conclusions: LncRNAs involved in the TNF signaling pathway may contribute to the inflammatory response and clinical severity of COVID-19. Accordingly, they may serve as potential diagnostic and prognostic biomarkers and as promising therapeutic targets for the management of COVID-19.

  • Open Access

    Epigenetic and Molecular Regulation of the IL-6 Axis in COVID-19: A Narrative Review of the Most Important microRNA-Mediated Mechanisms Involved in Cytokine Storm and Therapeutic Perspectives

    by Mahdi Atabaki, Narges Arbabi

    Context: The COVID-19 pandemic, caused by SARS-CoV-2, is characterized by a severe hyperinflammatory response driven by a cytokine storm, in which interleukin-6 (IL-6) plays a central pathogenic role. This review examines the epigenetic regulation of the IL-6 axis by microRNAs (miRNAs) in the pathophysiology of COVID-19. Evidence Acquisition: This review examines evidence on specific miRNAs involved in the regulation of IL-6 signaling, including miR-155, miR-451a, miR-98 - 5p, miR-146a, miR-106a, and miR-20a, with particular attention to their effects on the Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa B (NF-κB) pathways. Systems biology approaches were also considered to identify key miRNA regulatory hubs within the inflammatory network. Results: In severe COVID-19, miR-155 amplifies inflammation by repressing negative regulators such as SOCS1, whereas downregulation of miR-451a leads to IL-6 receptor overexpression and increased inflammatory sensitivity. In contrast, protective miRNAs such as miR-146a act as molecular brakes against excessive innate immune responses. Reduced levels of miR-98 - 5p, miR-106a, and miR-20a are associated with poor clinical outcomes and increased mortality. These miRNAs have been identified as key regulatory hubs within highly interconnected inflammatory networks. Their stability in biofluids also makes them promising noninvasive biomarkers for early diagnosis, prognostication, and monitoring of disease severity. Conclusions: miRNAs involved in the IL-6 signaling axis may serve as valuable biomarkers and therapeutic targets in COVID-19. Emerging approaches, including miRNA mimics and antagomiRs, may help restore immune homeostasis and mitigate the IL-6-driven cytokine storm. Longitudinal studies are needed to translate these epigenetic findings into routine clinical practice and support the precision management of COVID-19 and its long-term sequelae.

  • Open Access

    Frequency of Trichomonas vaginalis in Pap Smears of Women Referring to the Gynecology Clinics in Zahedan from 2013 to 2022

    by Hadi Mirahmadi, Yekta Metanat, Seyed Ghader Azizi, Farahnaz Farzaneh, Maliheh Metanat, Ahmad Mehravaran, Narges Arbabi

    Background: Trichomoniasis, caused by Trichomonas vaginalis, is a common sexually transmitted disease that can lead to complications such as vaginitis, pelvic infections, preterm delivery, and increased risks of HIV and HPV transmission. Women often experience foul-smelling discharge and inflammatory symptoms, though about half of cases are asymptomatic. Various diagnostic methods, including Pap smears, are used for detection. Objectives: This study investigated the prevalence of trichomoniasis among women referred to gynecology clinics in Zahedan using Pap smear testing. Methods: This descriptive, cross-sectional, retrospective study was conducted based on the records of 20,607 pregnant women and those coming for periodic checkups referred to gynecology clinics under the coverage of Zahedan University of Medical Sciences in Zahedan from 2013 to 2022. The data included influential factors such as age, number of pregnancies, contraceptive methods, and number of abortions and were analyzed using the chi-square test. Results: A ten-year study involving 20,607 patients found the prevalence of trichomoniasis with 103 positive cases. Of those, 69.9% showed inflammation, 75.7% had fungal infections, and 22.35% had bacterial infections. The highest infection rates were in women aged 35 to 45 years, particularly those with three to five pregnancies using fallopian tube ligation. Significant associations were found between age, number of pregnancies, contraceptive method, and infection prevalence (P < 0.05), along with a significant relationship between inflammation and trichomoniasis (P = 0.007). Conclusions: This study reveals that trichomoniasis prevalence in Zahedan is relatively low compared to other studies. More research and better health information about symptoms and transmission are needed. It is also important to examine the infection's prevalence in men and use accurate diagnostic methods to avoid misdiagnosis. Educating women about the risks of sexually transmitted infections can help reduce prevalence.

  • Association between common variants in vitamin D receptor gene and susceptibility to Non-Hodgkin’s lymphoma: a case-control study

    by Mohammad Ali Mashhadi, Narges Arbabi, Nahid Sepehri Rad, Saman Sargazi, Mahdiyeh Harati-Sadegh

    Vitamin D (VDR)-mediated signaling contributes to the cell signaling pathways that affect cancer development. This study is conducted on 104 patients diagnosed with non-Hodgkin’s lymphoma (NHL) and 246 healthy subjects to investigate the link between five genetic variants spanning the VDR gene and the risk of this malignancy in Iranian subjects. The PCR-RFLP method was used for the analysis of BsmI (rs1544410), ApaI (rs7975232), FokI (rs2228570) and TaqI (rs731236) variants. A simple Tetra-ARMS-PCR technique was employed for the genotyping of the Cdx2 (rs11568820) variant. No significant link was found between both groups regarding ApaI (rs7975232) and FokI (rs2228570) variants (P > 0.05). Also, different genetic models of TaqI (rs731236), BsmI (rs1544410) and Cdx2 (rs11568820) polymorphisms were significantly correlated to decreased risk of NHL (Odd ratios TaqI (rs731236) and BsmI (rs1544410) among NHL case and control subjects. Our findings indicated that functional variants of the VDR gene are linked to a decreased risk of NHL in our population. Further replication studies in different ethnic groups are needed to validate our results.


  • Association of VEGFA gene polymorphisms with susceptibility to non-Hodgkin's lymphoma: Evidences from population-based and in silico studies

    by Mohammad Ali Mashhadi, Narges Arbabi, Saman Sargazi, Fatemeh Kazemi-Lomedasht, Danial Jahantigh, Ebrahim Miri-Moghaddam


  • Open Access

    Association between VDR Gene Polymorphisms (rs 1544410, rs 7975232, rs 2228570, rs 731236 and rs 11568820) and Susceptibility to Breast Cancer in a Sample of Southeastern Iranian Population

    by Seyed Mehdi Hashemi, Narges Arbabi, Mohammad Hashemi, Mohammad Ali Mashhadi, Abolghasem Allahyari, Masoud Sadeghi

    Background: Vitamin D receptor (VDR) is a key nuclear receptor that is associated with the risk and progression of breast cancer (BC). Objectives: The present study investigated the Fok1, Bsm1, Taq1 and Cdx2 polymorphisms in the VDR gene and susceptibility to BC in a sample of Southeastern Iranian population. Methods: This case-control study was conducted on 180 women with BC and 178 age-matched healthy women. RFLP-PCR method was used for analysis of Bsm1 (rs 1544410), Apa1 (rs 7975232), Fok1 (rs 2228570) and Taq1 (rs 731236) and also TETRA-ARMS method for Cdx2 (rs 11568820). Results: No significant correlation was found between polymorphisms of Taq1, Fok1 and Apa1 with BC, but was for Bsm1 (odds ratio (OR) = 3.452, 95% CI 1.769 - 6.738; P < 0.001). Also, there was a significant correlation between the case and control groups for Cdx2 (OR = 3.720, 95% CI 2.224 - 6.225; P < 0.001) and allele A in Cdx2 had just significant correlation with BC. Conclusions: The present study findings showed that there were significant correlations between Bsm1 and Cdx2 polymorphisms with BC in women of Sistan and Baluchestan Province (southeastern Iran). Also, signals of Rs1544410-Bsm1 and Rs11568820-Cdx2 positions were difference with routes of estrogen and progesterone per person and they probably act independently. Keywords: Breast Cancer; Polymorphism; VDR; Southeastern Iran